20/09/2026 · Blog

PT-141 Research Peptide: Same Molecule Name, Very Different Product Standards

PT-141 (Bremelanotide) specification sheet, CAS 189691-06-3

PT-141 and bremelanotide are often treated as interchangeable search terms online. Chemically, that makes sense. From a professional sourcing perspective, however, the product name is only the beginning.

A research-grade PT-141 peptide and an FDA-approved finished pharmaceutical product are not automatically equivalent.

For laboratories and B2B buyers, identity, purity and batch documentation matter.

What Is PT-141?

PT-141 (Bremelanotide, CAS 189691-06-3) is a synthetic cyclic heptapeptide and melanocortin receptor agonist.

Its structure is commonly represented as:

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

PT-141 is studied in research involving:

  • melanocortin receptor signaling;
  • MC4R-related pathways;
  • neuroendocrine signaling;
  • peptide-receptor interactions;
  • central signaling mechanisms.

PT-141 vs. Vyleesi: Why the Difference Matters

Bremelanotide is also the active ingredient in the FDA-approved prescription medicine Vyleesi.

But that approval applies to a specific regulated drug product, manufacturing process, formulation, strength, delivery system and approved indication.

It does not mean that every material labelled “PT-141” or “Bremelanotide” is an approved pharmaceutical product.

For research procurement, buyers should verify the supplied material on its own analytical documentation.

What Do PT-141 Reviews Say?

Online experiences are highly mixed.

Some users describe perceived increases in desire or arousal.

Others report little noticeable benefit or unwanted experiences such as:

  • nausea;
  • headache;
  • flushing;
  • fatigue;
  • injection-site discomfort.

These anecdotes cannot establish product quality, safety or efficacy.

The peptide source, actual identity, impurities, other substances and individual factors are rarely controlled in online reviews.

For professional research, analytical evidence is more valuable than testimonials.

Choosing a PT-141 Supplier: What Should B2B Buyers Verify?

1. Confirm Identity

The documentation should clearly identify the material as PT-141 / Bremelanotide and match the expected molecular specification.

2. Review HPLC Purity

PT-141 HPLC testing can provide information about chromatographic purity and related impurities.

However:

99% HPLC does not by itself prove that the major peak is PT-141.

3. Review LC-MS or MS Data

Where available, PT-141 LC-MS or mass spectrometry provides additional evidence supporting molecular identity.

For professional buyers, purity and identity should be evaluated together.

4. Ask for a Batch-Specific COA

A professional PT-141 Certificate of Analysis should correspond to the actual production lot.

Depending on project requirements, buyers may consider reviewing:

  • HPLC purity;
  • MS or LC-MS identity;
  • batch/lot number;
  • impurity information;
  • molecular specifications;
  • SDS;
  • storage conditions;
  • relevant QC documentation.

PT-141 Research Peptide from Sunone

Sunone (Hong Kong) Biopharmaceutical International Technology Co., Limited supplies PT-141 for qualified laboratory research, analytical development and manufacturing applications.

Current product information includes:

Product: PT-141
Synonyms: Bremelanotide / PT141
CAS: 189691-06-3
Molecular Formula: C50H68N14O10
Molecular Weight: 1025.16 g/mol
Grade: Research Grade
Purity: ≥99% by HPLC
Form: Lyophilized Powder
Documentation: COA, HPLC and MS data available according to batch specification

Sunone can also discuss B2B packaging, labeling and OEM/ODM requirements for qualified projects.

Looking for a PT-141 research peptide supplier with batch-specific analytical documentation?

View PT-141 Specifications :

Send Sunone your target quantity, purity requirement, packaging format and required analytical documents to discuss a B2B quotation.

PT-141 FAQ

Is PT-141 the same molecule as Bremelanotide?

PT-141 is the research name commonly associated with bremelanotide. However, a research-grade material should not be represented as equivalent or interchangeable with a regulated finished drug product solely because the active molecule has the same name.

What is the CAS number for PT-141?

PT-141 / Bremelanotide is commonly identified as CAS 189691-06-3.

What should buyers request from a PT-141 supplier?

Professional buyers may consider reviewing batch-specific COA, HPLC purity, MS or LC-MS identity data, product specifications, SDS and lot traceability.

Does 99% HPLC prove PT-141 identity?

No. HPLC purity and molecular identity answer different analytical questions. Appropriate identity testing can provide additional confirmation.

Where can I request PT-141 research peptide specifications?

Qualified B2B buyers can review the Sunone PT-141 product page and submit their quantity and analytical-documentation requirements for quotation.


Leave a Reply

Your email address will not be published. Required fields are marked *

Apenas para uso em pesquisa e fabricação. Os produtos são fornecidos a empresas qualificadas em conformidade com as leis e regulamentos do país de destino. Não se destinam a uso pessoal, diagnóstico ou terapêutico, salvo se devidamente registrados e autorizados.